AU Patent

AU2022200590B2 — Pharmaceutical compositions comprising meloxicam

Assigned to Axsome Therapeutics Inc · Expires 2024-05-16 · 2y expired

What this patent protects

The present application is directed to methods for treating migraines comprising oral administration of meloxicam and rizatriptan. The methods provide for rapid pain relief.

USPTO Abstract

The present application is directed to methods for treating migraines comprising oral administration of meloxicam and rizatriptan. The methods provide for rapid pain relief.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022200590B2
Jurisdiction
AU
Classification
—
Expires
2024-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Axsome Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.